Menu
Close X
Nippon India Pharma Fund(G)

Scheme Returns

-4.56%

Category Returns

-5.96%

Riskometer

  • Low
  • Low to moderate
  • Moderate
  • Moderately High
  • High
  • Very High

NAV Chart

Trailing Returns

1 Day 1 week 1 Mth 3 Mth 1 Yrs 3 Yrs 4 Yrs 5 Yrs Since Inception
Nippon India Pharma Fund(G) 0.92 -1.38 -4.56 0.10 35.69 18.23 21.87 27.37 21.05
Equity - Sectoral Fund - Pharma & Health Care 0.57 -1.26 -5.96 -3.45 30.97 20.53 27.89 23.93 17.67

* Equity - Returns upto 1 year are absolute and over 1 year are CAGR.

* Debt - Returns upto 1 year are annualized and over 1 year are CAGR.

  • AMC

    Nippon Life India Asset Management Limited

  • Fund

    Nippon India Mutual Fund

Snapshot

  • Inception Date

    05-Jun-2004

  • Initial Price

    ₹10

  • Entry Load

    --

  • Size of Fund(in Cr.)

    451,077.39

  • Scheme Plan

    --

  • Scheme Class

    Equity - Sectoral Fund - Pharma & Health Care

  • Objectives

    The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

  • Scheme Type

    Open ended scheme

  • Min. Investment

    ₹5,000

  • Exit Load

    1

  • Latest NAV

    500.8806

  • Fund Manager

    Mr. Sailesh Raj Bhan

  • Fund Manager Profile

    Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date

  • Fund Information

  • AMC

    Nippon Life India Asset Management Limited

  • Address

    4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013

  • Phone

    022-68087000

  • Fax

    022-68087097

  • Email

    customercare@nipponindiaim.in

  • Website

    https://mf.nipponindiaim.com/

  • Registrar Agent

  • Registrar

    KFin Technologies Limited

  • Address

    Selenium Building, Tower-B, Plot No 31 & 32 Financial District,Nanakramguda, Serilingampally Hyderabad - 500 032

  • Phone

    (040) 23312454 23320751 23320752

  • Fax

    (040) 23311968

  • Email

    customercare@karvy.com

  • Website

    https://mfs.kfintech.com/

Portfolio Details

Allocation
Equity : 95.57
Others : 4.43

Companies - Holding Percentage

Company Market Value hold percentage
Sun Pharmaceutical Industries Limited 121220.34 13.95
Divi's Laboratories Limited 79557.86 9.16
Lupin Limited 70062.79 8.06
Cipla Limited 48104.25 5.54
Apollo Hospitals Enterprise Limited 45562.93 5.24
Dr. Reddy's Laboratories Limited 44598.91 5.13
Triparty Repo 38563.96 4.44
Vijaya Diagnostic Centre Limited 30230.62 3.48
Ajanta Pharma Limited 29400.37 3.38
JB Chemicals & Pharmaceuticals Limited 25078.18 2.89
Abbott India Limited 25034.7 2.88
Gland Pharma Limited 24766.5 2.85
Mankind Pharma Limited 24027.33 2.77
Aurobindo Pharma Limited 23777.23 2.74
GlaxoSmithKline Pharmaceuticals Limited 22587.27 2.6
MedPlus Health Services Limited 20516.33 2.36
Zydus Lifesciences Limited 20031.33 2.31
Narayana Hrudayalaya Limited 19107.58 2.2
Thyrocare Technologies Limited 16514.12 1.9
Pfizer Limited 16224.02 1.87
Torrent Pharmaceuticals Limited 16120.99 1.86
Alkem Laboratories Limited 16032.33 1.85
Sanofi India Limited 15645.37 1.8
Fortis Healthcare Limited 14368.1 1.65
Sanofi Consumer Healthcare India Limited 10521.96 1.21
Syngene International Limited 9676.05 1.11
Orchid Pharma Limited 9082.87 1.05
Dr. Lal Path Labs Limited 9000.06 1.04
Indoco Remedies Limited 5695.6 0.66
AstraZeneca Pharma India Limited 4885.88 0.56
Emcure Pharmaceuticals Limited 4317.3 0.5
Healthcare Global Enterprises Limited 4051.04 0.47
Krishna Institute Of Medical Sciences Limited 2516.27 0.29
Concord Biotech Limited 2045.14 0.24
Cash Margin - CCIL 209.88 0.02
Net Current Assets -270.88 -0.03

Sectors - Holding Percentage

Sector hold percentage
Healthcare 94.45%
Miscellaneous 4.44%
Business Services 1.11%

Divident Details

Scheme Name Date Dividend (%)
No Data Found

Alternative Funds From Category

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
HDFC Pharma and Healthcare Fund - Growth Option 506.59 -2.29 5.45 25.39 50.99 0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 2552.23 -4.13 2.02 21.49 47.91 23.16
DSP Healthcare Fund - Regular Plan - Growth 1243.08 -2.09 6.68 22.9 46.87 21.24
UTI Healthcare Fund - Regular Plan - Growth Option 5.42 -3.43 3.44 23.56 44.48 19.66
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 138.39 -3.03 3.77 21.21 44.12 18.22
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 7.7 -2.14 4.88 18.56 43.61 22.9
LIC MF Healthcare Fund-Regular Plan-Growth 51.46 -3.4 4.36 20.08 43.41 15.82
quant Healthcare Fund - Growth Option - Regular Plan 137.36 -7.52 -4.87 13.72 42.44 0
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 512.42 -5.29 -1.12 15.76 39.29 19.22
Mirae Asset Healthcare Fund -Regular Growth 1583.14 -5.94 -1.27 18.18 37.48 16.84

Other Funds From - Nippon India Pharma Fund(G)

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
Nippon India Small Cap Fund - Growth Plan - Growth Option 62259.56 -6.6 -3.54 7.08 32.49 25.97
Nippon India Small Cap Fund - Growth Plan - Growth Option 61027.03 -6.6 -3.54 7.08 32.49 25.97
Nippon India Small Cap Fund - Growth Plan - Growth Option 60999.55 -6.6 -3.54 7.08 32.49 25.97
Nippon India Small Cap Fund - Growth Plan - Growth Option 60372.55 -6.6 -3.54 7.08 32.49 25.97
Nippon India Small Cap Fund - Growth Plan - Growth Option 56468.75 -6.6 -3.54 7.08 32.49 25.97
Nippon India Small Cap Fund - Growth Plan - Growth Option 51566.11 -6.6 -3.54 7.08 32.49 25.97
Nippon India Small Cap Fund - Growth Plan - Growth Option 50422.78 -6.6 -3.54 7.08 32.49 25.97
CPSE ETF 46793.08 -8.87 -14.26 -0.66 54.76 43.57
CPSE ETF 46098.89 -8.87 -14.26 -0.66 54.76 43.57
Nippon India Small Cap Fund - Growth Plan - Growth Option 46044.13 -6.6 -3.54 7.08 32.49 25.97